Qin, Y.; Imobersteg, S.; Blanc, A.; Frank, S.; Schibli, R.; Béhé, M.P.; Grzmil, M.
Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy. Pharmaceutics 2020, 12, 1088.
https://doi.org/10.3390/pharmaceutics12111088
AMA Style
Qin Y, Imobersteg S, Blanc A, Frank S, Schibli R, Béhé MP, Grzmil M.
Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy. Pharmaceutics. 2020; 12(11):1088.
https://doi.org/10.3390/pharmaceutics12111088
Chicago/Turabian Style
Qin, Yun, Stefan Imobersteg, Alain Blanc, Stephan Frank, Roger Schibli, Martin P. Béhé, and Michal Grzmil.
2020. "Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy" Pharmaceutics 12, no. 11: 1088.
https://doi.org/10.3390/pharmaceutics12111088
APA Style
Qin, Y., Imobersteg, S., Blanc, A., Frank, S., Schibli, R., Béhé, M. P., & Grzmil, M.
(2020). Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy. Pharmaceutics, 12(11), 1088.
https://doi.org/10.3390/pharmaceutics12111088